Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Pathways
Variants search result for Homo sapiens
(View Results for all Objects and Ontologies)


390 records found for search term Ung
Refine Term:
Assembly:
    Chr  
Sort By:
           Export CSV TAB Print

RGD IDSymbolVariant TypeNameTraitClinical SignificanceChrStartStopSpeciesAnnotationsMatch
28870487CV869173single nucleotide variantNM_080911.3(UNG):c.*2C>AHyper-IgM syndrome type 5 [RCV001113585]uncertain significance12109109971109109971Human1name
11604077CV315876single nucleotide variantNM_080911.3(UNG):c.-51A>THyper-IgM syndrome type 5 [RCV000305902]uncertain significance12109097629109097629Human1name
11663046CV330261single nucleotide variantNM_080911.3(UNG):c.-73C>THyper-IgM syndrome type 5 [RCV000391677]uncertain significance12109097607109097607Human1name
28873637CV869166single nucleotide variantNM_080911.3(UNG):c.-51A>GHyper-IgM syndrome type 5 [RCV001115106]uncertain significance12109097629109097629Human1name
28873640CV869167single nucleotide variantNM_080911.3(UNG):c.-50G>AHyper-IgM syndrome type 5 [RCV001115107]uncertain significance12109097630109097630Human1name
11661733CV315888duplicationNM_080911.3(UNG):c.*788dupHyperimmunoglobulin M syndrome [RCV001844117]likely benign12109110749109110750Human1name
11648031CV323026single nucleotide variantNM_080911.3(UNG):c.*159G>AHyper-IgM syndrome type 5 [RCV000279628]uncertain significance12109110128109110128Human1name
11612359CV323034single nucleotide variantNM_080911.3(UNG):c.*522A>GHyper-IgM syndrome type 5 [RCV000407340]uncertain significance12109110491109110491Human1name
11609036CV323036single nucleotide variantNM_080911.3(UNG):c.*545A>GHyper-IgM syndrome type 5 [RCV000362912]uncertain significance12109110514109110514Human1name
11599338CV323043single nucleotide variantNM_080911.3(UNG):c.*708T>CHyper-IgM syndrome type 5 [RCV000264692]likely benign|uncertain significance12109110677109110677Human1name
11609869CV323044single nucleotide variantNM_080911.3(UNG):c.*880A>THyper-IgM syndrome type 5 [RCV000373697]uncertain significance12109110849109110849Human1name
11656887CV329083single nucleotide variantNM_080911.3(UNG):c.*281C>THyper-IgM syndrome type 5 [RCV000336984]uncertain significance12109110250109110250Human1name
11618179CV329092single nucleotide variantNM_080911.3(UNG):c.*463C>THyper-IgM syndrome type 5 [RCV000311250]likely benign|uncertain significance12109110432109110432Human1name
11654161CV329094single nucleotide variantNM_080911.3(UNG):c.*537G>AHyper-IgM syndrome type 5 [RCV000315261]uncertain significance12109110506109110506Human1name
11617936CV329096single nucleotide variantNM_080911.3(UNG):c.*655A>CHyper-IgM syndrome type 5 [RCV000309188]uncertain significance12109110624109110624Human1name
11622952CV329107single nucleotide variantNM_080911.3(UNG):c.*699T>CHyper-IgM syndrome type 5 [RCV000366239]uncertain significance12109110668109110668Human1name
11620928CV330267single nucleotide variantNM_080911.3(UNG):c.*109A>GHyper-IgM syndrome type 5 [RCV000342482]uncertain significance12109110078109110078Human1name
11623347CV330272single nucleotide variantNM_080911.3(UNG):c.*111A>THyper-IgM syndrome type 5 [RCV000371536]uncertain significance12109110080109110080Human1name
11664011CV330276single nucleotide variantNM_080911.3(UNG):c.*313C>GHyper-IgM syndrome type 5 [RCV000401327]uncertain significance12109110282109110282Human1name
11621564CV330282single nucleotide variantNM_080911.3(UNG):c.*500C>GHyperimmunoglobulin M syndrome [RCV001844116]uncertain significance12109110469109110469Human1name
11646398CV330283single nucleotide variantNM_080911.3(UNG):c.*611C>THyper-IgM syndrome type 5 [RCV000270439]uncertain significance12109110580109110580Human1name
11655022CV330291single nucleotide variantNM_080911.3(UNG):c.*719G>AHyper-IgM syndrome type 5 [RCV000322389]uncertain significance12109110688109110688Human1name
28870490CV869174single nucleotide variantNM_080911.3(UNG):c.*129C>THyper-IgM syndrome type 5 [RCV001113586]uncertain significance12109110098109110098Human1name
28870494CV869175single nucleotide variantNM_080911.3(UNG):c.*376C>GHyper-IgM syndrome type 5 [RCV001113587]uncertain significance12109110345109110345Human1name
28910881CV869176single nucleotide variantNM_080911.3(UNG):c.*445C>THyper-IgM syndrome type 5 [RCV001109581]uncertain significance12109110414109110414Human1name
28910882CV869177single nucleotide variantNM_080911.3(UNG):c.*573G>CHyper-IgM syndrome type 5 [RCV001109582]uncertain significance12109110542109110542Human1name
28867502CV869178single nucleotide variantNM_080911.3(UNG):c.*705T>CHyper-IgM syndrome type 5 [RCV001111857]uncertain significance12109110674109110674Human1name
28867505CV869179single nucleotide variantNM_080911.3(UNG):c.*858T>GHyper-IgM syndrome type 5 [RCV001111858]uncertain significance12109110827109110827Human1name
126775076CV1030632single nucleotide variantNM_080911.3(UNG):c.802-8T>AHyper-IgM syndrome type 5 [RCV001347963]uncertain significance12109109821109109821Human1name
127278842CV1079072single nucleotide variantNM_080911.3(UNG):c.133-7C>THyper-IgM syndrome type 5 [RCV001408758]likely benign12109098425109098425Human1name
127314686CV1122264single nucleotide variantNM_080911.3(UNG):c.622+9G>THyper-IgM syndrome type 5 [RCV001457774]likely benign12109102936109102936Human1name
151724507CV1439987single nucleotide variantNM_080911.3(UNG):c.623-2A>GHyper-IgM syndrome type 5 [RCV002040511]likely pathogenic12109103431109103431Human1name
151728660CV1444468single nucleotide variantNM_080911.3(UNG):c.801+5G>AHyper-IgM syndrome type 5 [RCV001945816]uncertain significance12109103616109103616Human1name
156299741CV2075820single nucleotide variantNM_080911.3(UNG):c.133-8A>CHyper-IgM syndrome type 5 [RCV002857110]likely benign12109098424109098424Human1name
155977038CV2151252single nucleotide variantNM_080911.3(UNG):c.622+6C>GHyper-IgM syndrome type 5 [RCV003033699]uncertain significance12109102933109102933Human1name
404996576CV2892401single nucleotide variantNM_080911.3(UNG):c.132+1G>AHyper-IgM syndrome type 5 [RCV003513396]likely pathogenic12109097812109097812Human1name
402473016CV2945762single nucleotide variantNM_080911.3(UNG):c.133-2A>GHyper-IgM syndrome type 5 [RCV003624665]likely pathogenic12109098430109098430Human1name
402481401CV3019995single nucleotide variantNM_080911.3(UNG):c.802-9C>THyper-IgM syndrome type 5 [RCV003626099]likely benign12109109820109109820Human1name
405184327CV3124108single nucleotide variantNM_080911.3(UNG):c.435+9A>GHyper-IgM syndrome type 5 [RCV003820304]likely benign12109099293109099293Human1name
405233713CV3145024single nucleotide variantNM_080911.3(UNG):c.623-9T>CHyper-IgM syndrome type 5 [RCV003853281]likely benign12109103424109103424Human1name
11600322CV315878single nucleotide variantNM_080911.3(UNG):c.623-9T>AHyper-IgM syndrome type 5 [RCV001044991]uncertain significance12109103424109103424Human1name
11619566CV329059single nucleotide variantNM_080911.3(UNG):c.533+6G>AHyper-IgM syndrome type 5 [RCV000625198]|UNG-related disorder [RCV003977892]|not provided [RCV003992268]likely benign|conflicting interpretations of pathogenicity|uncertain significance12109102005109102005Human1name , trait , alternate_id
11620623CV329111single nucleotide variantNM_080911.3(UNG):c.*1018A>GHyper-IgM syndrome type 5 [RCV000338933]uncertain significance12109110987109110987Human1name
11614978CV330299single nucleotide variantNM_080911.3(UNG):c.*1013T>AHyper-IgM syndrome type 5 [RCV000281414]benign|likely benign12109110982109110982Human1name
408383748CV3525826single nucleotide variantNM_080911.3(UNG):c.339+6T>Cnot specified [RCV004766736]uncertain significance12109098644109098644Humanname
14707216CV652201single nucleotide variantNM_080911.3(UNG):c.802-6T>CHyper-IgM syndrome type 5 [RCV000792257]uncertain significance12109109823109109823Human1name
15115971CV775961single nucleotide variantNM_080911.3(UNG):c.436-5C>Tnot provided [RCV000939583]likely benign12109101897109101897Humanname
38495723CV960020single nucleotide variantNM_080911.3(UNG):c.340-3C>THyper-IgM syndrome type 5 [RCV001225908]uncertain significance12109099186109099186Human1name
127267652CV1079073single nucleotide variantNM_080911.3(UNG):c.339+15G>AHyper-IgM syndrome type 5 [RCV001404168]likely benign12109098653109098653Human1name
150469951CV1219159single nucleotide variantNM_080911.3(UNG):c.623-67T>Cnot provided [RCV001614911]benign12109103366109103366Humanname
150497448CV1219408single nucleotide variantNM_080911.3(UNG):c.802-47T>Anot provided [RCV001620077]benign12109109782109109782Humanname
150436594CV1220571single nucleotide variantNM_080911.3(UNG):c.802-48A>Tnot provided [RCV001609555]benign12109109781109109781Humanname
150457204CV1237042duplicationNM_080911.3(UNG):c.622+42dupnot provided [RCV001648721]benign12109102947109102948Humanname
150501857CV1241056duplicationNM_080911.3(UNG):c.534-25dupnot provided [RCV001656952]|not specified [RCV003487612]benign12109102808109102809Humanname
152117464CV1524178duplicationNM_080911.3(UNG):c.801+27dupHyper-IgM syndrome type 5 [RCV002135276]benign12109103630109103631Human1name
152042355CV1537958single nucleotide variantNM_080911.3(UNG):c.802-20T>GHyper-IgM syndrome type 5 [RCV002165855]likely benign12109109809109109809Human1name
152063046CV1542196single nucleotide variantNM_080911.3(UNG):c.622+16C>THyper-IgM syndrome type 5 [RCV002208931]likely benign12109102943109102943Human1name
152079607CV1550006single nucleotide variantNM_080911.3(UNG):c.533+18G>AHyper-IgM syndrome type 5 [RCV002192857]likely benign12109102017109102017Human1name
152133083CV1557413single nucleotide variantNM_080911.3(UNG):c.436-19G>AHyper-IgM syndrome type 5 [RCV002137188]likely benign12109101883109101883Human1name
152135282CV1560333single nucleotide variantNM_080911.3(UNG):c.533+15C>GHyper-IgM syndrome type 5 [RCV002137454]likely benign12109102014109102014Human1name
152152207CV1572492single nucleotide variantNM_080911.3(UNG):c.801+14T>CHyper-IgM syndrome type 5 [RCV002139689]likely benign12109103625109103625Human1name
152132160CV1585035single nucleotide variantNM_080911.3(UNG):c.339+11A>CHyper-IgM syndrome type 5 [RCV002083009]|not provided [RCV004704712]likely benign12109098649109098649Human1name
152136352CV1587836single nucleotide variantNM_080911.3(UNG):c.340-20C>THyper-IgM syndrome type 5 [RCV002083556]likely benign12109099169109099169Human1name
152118637CV1593515single nucleotide variantNM_080911.3(UNG):c.623-13C>GHyper-IgM syndrome type 5 [RCV002097841]likely benign12109103420109103420Human1name
152120069CV1612227single nucleotide variantNM_080911.3(UNG):c.435+15T>CHyper-IgM syndrome type 5 [RCV002135597]likely benign12109099299109099299Human1name
152168955CV1614011single nucleotide variantNM_080911.3(UNG):c.533+17G>THyper-IgM syndrome type 5 [RCV002161287]likely benign12109102016109102016Human1name
152165175CV1649015single nucleotide variantNM_080911.3(UNG):c.534-14T>CHyper-IgM syndrome type 5 [RCV002204187]likely benign12109102825109102825Human1name
152147415CV1656137single nucleotide variantNM_080911.3(UNG):c.132+16G>THyper-IgM syndrome type 5 [RCV002220265]likely benign12109097827109097827Human1name
152090786CV1662023single nucleotide variantNM_080911.3(UNG):c.339+17A>CHyper-IgM syndrome type 5 [RCV002132017]benign12109098655109098655Human1name
152054633CV1665470single nucleotide variantNM_080911.3(UNG):c.132+14T>GHyper-IgM syndrome type 5 [RCV002089557]likely benign12109097825109097825Human1name
155268772CV1705599deletionNM_080911.3(UNG):c.802-48delnot provided [RCV002286206]likely benign12109109764109109764Humanname
156269881CV1870645single nucleotide variantNM_080911.3(UNG):c.435+11C>THyper-IgM syndrome type 5 [RCV003060675]likely benign12109099295109099295Human1name
156400193CV1897531single nucleotide variantNM_080911.3(UNG):c.623-11C>GHyper-IgM syndrome type 5 [RCV002584791]likely benign12109103422109103422Human1name
156080054CV1959852single nucleotide variantNM_080911.3(UNG):c.801+18T>CHyper-IgM syndrome type 5 [RCV002569880]likely benign12109103629109103629Human1name
156315086CV2017932single nucleotide variantNM_080911.3(UNG):c.132+19C>THyper-IgM syndrome type 5 [RCV002671855]likely benign12109097830109097830Human1name
155962905CV2037827single nucleotide variantNM_080911.3(UNG):c.339+18C>THyper-IgM syndrome type 5 [RCV002776357]likely benign12109098656109098656Human1name
156000502CV2045531single nucleotide variantNM_080911.3(UNG):c.622+11G>AHyper-IgM syndrome type 5 [RCV002756178]likely benign12109102938109102938Human1name
402473178CV2960124single nucleotide variantNM_080911.3(UNG):c.622+19G>CHyper-IgM syndrome type 5 [RCV003624701]likely benign12109102946109102946Human1name
402480499CV3017004single nucleotide variantNM_080911.3(UNG):c.339+13A>GHyper-IgM syndrome type 5 [RCV003625923]likely benign12109098651109098651Human1name
402474748CV3074712single nucleotide variantNM_080911.3(UNG):c.622+20A>THyper-IgM syndrome type 5 [RCV003625054]likely benign12109102947109102947Human1name
405172732CV3122863single nucleotide variantNM_080911.3(UNG):c.133-19C>THyper-IgM syndrome type 5 [RCV003819261]likely benign12109098413109098413Human1name
405161599CV3125063single nucleotide variantNM_080911.3(UNG):c.623-15C>AHyper-IgM syndrome type 5 [RCV003818334]likely benign12109103418109103418Human1name
405052554CV3138306single nucleotide variantNM_080911.3(UNG):c.801+16T>CHyper-IgM syndrome type 5 [RCV003832150]likely benign12109103627109103627Human1name
402466417CV3173571single nucleotide variantNM_080911.3(UNG):c.802-12G>CHyper-IgM syndrome type 5 [RCV003873045]likely benign12109109817109109817Human1name
404992484CV3183875single nucleotide variantNM_080911.3(UNG):c.802-15C>AHyper-IgM syndrome type 5 [RCV003881648]likely benign12109109814109109814Human1name
11623274CV329058single nucleotide variantNM_080911.3(UNG):c.435+15T>AHyper-IgM syndrome type 5 [RCV000370574]conflicting interpretations of pathogenicity|uncertain significance12109099299109099299Human1name
11654338CV329110microsatelliteNM_080911.3(UNG):c.*866AT[5]Hyperimmunoglobulin M syndrome [RCV001844119]uncertain significance12109110835109110840Humanname
11613425CV330295microsatelliteNM_080911.3(UNG):c.*866AT[9]Hyperimmunoglobulin M syndrome [RCV001844118]likely benign12109110834109110835Humanname
597875330CV3743814single nucleotide variantNM_080911.3(UNG):c.802-18A>GHyper-IgM syndrome type 5 [RCV005069220]likely benign12109109811109109811Human1name
597953056CV3843892single nucleotide variantNM_080911.3(UNG):c.623-15C>THyper-IgM syndrome type 5 [RCV005190754]likely benign12109103418109103418Human1name
597888461CV3859505duplicationNM_080911.3(UNG):c.622+18dupHyper-IgM syndrome type 5 [RCV005200161]likely benign12109102944109102945Human1name
28868074CV872185single nucleotide variantNM_080911.3(UNG):c.622+10C>THyper-IgM syndrome type 5 [RCV001112233]benign|likely benign12109102937109102937Human1name
150459111CV1236046single nucleotide variantNM_080911.3(UNG):c.132+193A>Gnot provided [RCV001649017]benign12109098004109098004Humanname
150494993CV1241495single nucleotide variantNM_080911.3(UNG):c.133-221C>Tnot provided [RCV001655502]benign12109098211109098211Humanname
150469928CV1247903single nucleotide variantNM_080911.3(UNG):c.132+241T>Anot provided [RCV001670939]benign12109098052109098052Humanname
150461064CV1253195single nucleotide variantNM_080911.3(UNG):c.339+116A>Cnot provided [RCV001669524]benign12109098754109098754Humanname
405275445CV3204780single nucleotide variantNM_080911.3(UNG):c.133-110C>TUNG-related disorder [RCV003952159]likely benign12109098322109098322Humanname , trait , alternate_id
8603070CV45554deletionNM_080911.3(UNG):c.*70_*71delnot specified [RCV002281722]uncertain significance12109110037109110038Humanname
11658980CV323016single nucleotide variantNM_080911.3(UNG):c.6C>A (p.Ile2=)Hyper-IgM syndrome type 5 [RCV000353520]uncertain significance12109097685109097685Human1name
402470678CV3033657deletionNM_080911.3(UNG):c.623-10_623-9delHyper-IgM syndrome type 5 [RCV003624040]likely benign12109103423109103424Human1name
127318879CV1122261single nucleotide variantNM_080911.3(UNG):c.36C>T (p.Ser12=)Hyper-IgM syndrome type 5 [RCV001466389]likely benign12109097715109097715Human1name
127320163CV1156892deletionNM_080911.3(UNG):c.801+24_801+27delHyper-IgM syndrome type 5 [RCV001522495]benign12109103631109103634Human1name
150504960CV1211502duplicationNM_080911.3(UNG):c.802-53_802-48dupnot provided [RCV001595667]benign12109109763109109764Humanname
151709314CV1409191single nucleotide variantNM_080911.3(UNG):c.90G>T (p.Gly30=)Hyper-IgM syndrome type 5 [RCV001907650]|not specified [RCV005238020]likely benign|uncertain significance12109097769109097769Human1name
156295368CV1995276single nucleotide variantNM_080911.3(UNG):c.90G>A (p.Gly30=)Hyper-IgM syndrome type 5 [RCV002670930]likely benign12109097769109097769Human1name
156120616CV2013762microsatelliteNM_080911.3(UNG):c.801+19_801+22delHyper-IgM syndrome type 5 [RCV002740182]likely benign12109103623109103626Humanname
401917475CV2829876duplicationNM_080911.3(UNG):c.802-51_802-48dupnot provided [RCV003443920]likely benign12109109763109109764Humanname
404986075CV2854415single nucleotide variantNM_080911.3(UNG):c.60C>T (p.His20=)Hyper-IgM syndrome type 5 [RCV003512298]likely benign12109097739109097739Human1name
405092761CV3118840duplicationNM_080911.3(UNG):c.133-13_133-10dupHyper-IgM syndrome type 5 [RCV003811291]likely benign12109098418109098419Human1name
11624877CV329045single nucleotide variantNM_080911.3(UNG):c.81C>A (p.Ala27=)Hyper-IgM syndrome type 5 [RCV000391668]conflicting interpretations of pathogenicity|uncertain significance12109097760109097760Human1name
597868314CV3742909deletionNM_080911.3(UNG):c.801+19_801+21delHyper-IgM syndrome type 5 [RCV005068332]likely benign12109103628109103630Human1name
28873643CV869168single nucleotide variantNM_080911.3(UNG):c.36C>A (p.Ser12=)Hyper-IgM syndrome type 5 [RCV001115108]conflicting interpretations of pathogenicity|uncertain significance12109097715109097715Human1name
126910159CV1047645single nucleotide variantNM_080911.3(UNG):c.14A>G (p.Lys5Arg)Hyper-IgM syndrome type 5 [RCV001368796]uncertain significance12109097693109097693Human1name
127270168CV1100810single nucleotide variantNM_080911.3(UNG):c.126T>C (p.Asp42=)Hyper-IgM syndrome type 5 [RCV001430525]likely benign12109097805109097805Human1name
127305940CV1122262single nucleotide variantNM_080911.3(UNG):c.186C>T (p.Pro62=)Hyper-IgM syndrome type 5 [RCV001455361]likely benign12109098485109098485Human1name
152128317CV1581345single nucleotide variantNM_080911.3(UNG):c.120C>T (p.Ser40=)Hyper-IgM syndrome type 5 [RCV002099136]likely benign12109097799109097799Human1name
152091126CV1602810single nucleotide variantNM_080911.3(UNG):c.273C>G (p.Pro91=)Hyper-IgM syndrome type 5 [RCV002194312]likely benign12109098572109098572Human1name
152080371CV1620716single nucleotide variantNM_080911.3(UNG):c.267C>T (p.Asn89=)Hyper-IgM syndrome type 5 [RCV002112666]likely benign12109098566109098566Human1name
152073755CV1657653single nucleotide variantNM_080911.3(UNG):c.153C>G (p.Ala51=)Hyper-IgM syndrome type 5 [RCV002210319]likely benign12109098452109098452Human1name
153303904CV1686514single nucleotide variantNM_080911.3(UNG):c.16A>G (p.Thr6Ala)not provided [RCV002261948]uncertain significance12109097695109097695Humanname
156004513CV1906267single nucleotide variantNM_080911.3(UNG):c.105G>A (p.Gly35=)Hyper-IgM syndrome type 5 [RCV003098961]likely benign12109097784109097784Human1name
156439082CV1943950single nucleotide variantNM_080911.3(UNG):c.141A>G (p.Pro47=)Hyper-IgM syndrome type 5 [RCV003109035]likely benign12109098440109098440Human1name
156108254CV2140017deletionNM_080911.3(UNG):c.39del (p.Ser14fs)Hyper-IgM syndrome type 5 [RCV003002484]pathogenic12109097714109097714Human1name
156365530CV2192180single nucleotide variantNM_080911.3(UNG):c.273C>T (p.Pro91=)Hyper-IgM syndrome type 5 [RCV003065926]likely benign12109098572109098572Human1name
404989143CV2932063single nucleotide variantNM_080911.3(UNG):c.129G>A (p.Ala43=)Hyper-IgM syndrome type 5 [RCV003512623]likely benign12109097808109097808Human1name
402480846CV3022913single nucleotide variantNM_080911.3(UNG):c.138C>A (p.Ile46=)Hyper-IgM syndrome type 5 [RCV003626032]likely benign12109098437109098437Human1name
402471672CV3057356single nucleotide variantNM_080911.3(UNG):c.237C>T (p.Ala79=)Hyper-IgM syndrome type 5 [RCV003624303]likely benign12109098536109098536Human1name
402471677CV3057361single nucleotide variantNM_080911.3(UNG):c.168G>A (p.Glu56=)Hyper-IgM syndrome type 5 [RCV003624304]likely benign12109098467109098467Human1name
405211013CV3117749single nucleotide variantNM_080911.3(UNG):c.135C>T (p.Ala45=)Hyper-IgM syndrome type 5 [RCV003823348]likely benign12109098434109098434Human1name
405131495CV3163720single nucleotide variantNM_080911.3(UNG):c.189C>G (p.Ser63=)Hyper-IgM syndrome type 5 [RCV003854708]likely benign12109098488109098488Human1name
11622179CV329053single nucleotide variantNM_080911.3(UNG):c.204C>G (p.Ala68=)Hyper-IgM syndrome type 5 [RCV000357072]likely benign|conflicting interpretations of pathogenicity|uncertain significance12109098503109098503Human1name
11614193CV330262single nucleotide variantNM_080911.3(UNG):c.204C>T (p.Ala68=)Hyper-IgM syndrome type 5 [RCV000274915]uncertain significance12109098503109098503Human1name
597842550CV3831041single nucleotide variantNM_080911.3(UNG):c.102T>C (p.Ala34=)Hyper-IgM syndrome type 5 [RCV005172422]likely benign12109097781109097781Human1name
597963063CV3841363single nucleotide variantNM_080911.3(UNG):c.159T>C (p.Ala53=)Hyper-IgM syndrome type 5 [RCV005193466]likely benign12109098458109098458Human1name
597950930CV3847003single nucleotide variantNM_080911.3(UNG):c.150G>A (p.Lys50=)Hyper-IgM syndrome type 5 [RCV005190174]likely benign12109098449109098449Human1name
8603071CV45555single nucleotide variantNM_080911.3(UNG):c.246G>C (p.Leu82=)Hyper-IgM syndrome type 5 [RCV000030577]|not provided [RCV001705610]benign|likely benign|conflicting interpretations of pathogenicity12109098545109098545Human1name
13473997CV462161single nucleotide variantNM_080911.3(UNG):c.291C>T (p.Ser97=)Hyper-IgM syndrome type 5 [RCV000525628]|not provided [RCV004707325]benign12109098590109098590Human1name
15170048CV713314single nucleotide variantNM_080911.3(UNG):c.183G>A (p.Pro61=)Hyper-IgM syndrome type 5 [RCV000971936]|UNG-related disorder [RCV003972930]|not provided [RCV001702575]likely benign|conflicting interpretations of pathogenicity12109098482109098482Human1name , trait , alternate_id
15176862CV768873single nucleotide variantNM_080911.3(UNG):c.285A>G (p.Gly95=)Hyper-IgM syndrome type 5 [RCV000929016]likely benign12109098584109098584Human1name
127237936CV1079074single nucleotide variantNM_080911.3(UNG):c.513G>A (p.Arg171=)Hyper-IgM syndrome type 5 [RCV001397236]likely benign12109101979109101979Human1name
127237349CV1079075single nucleotide variantNM_080911.3(UNG):c.522G>A (p.Pro174=)Hyper-IgM syndrome type 5 [RCV001414891]likely benign12109101988109101988Human1name
127273694CV1079076single nucleotide variantNM_080911.3(UNG):c.681G>A (p.Lys227=)Hyper-IgM syndrome type 5 [RCV001406141]likely benign12109103491109103491Human1name
127239885CV1079077single nucleotide variantNM_080911.3(UNG):c.738G>T (p.Ser246=)Hyper-IgM syndrome type 5 [RCV001415454]likely benign12109103548109103548Human1name
127283356CV1079078single nucleotide variantNM_080911.3(UNG):c.906G>A (p.Lys302=)Hyper-IgM syndrome type 5 [RCV001411733]|UNG-related disorder [RCV003938702]likely benign12109109933109109933Human1name , trait , alternate_id
127242706CV1100811single nucleotide variantNM_080911.3(UNG):c.633T>C (p.Leu211=)Hyper-IgM syndrome type 5 [RCV001423799]likely benign12109103443109103443Human1name
127269765CV1100812single nucleotide variantNM_080911.3(UNG):c.744C>G (p.Gly248=)Hyper-IgM syndrome type 5 [RCV001430361]likely benign12109103554109103554Human1name
127316456CV1122263single nucleotide variantNM_080911.3(UNG):c.471T>C (p.His157=)Hyper-IgM syndrome type 5 [RCV001465546]likely benign12109101937109101937Human1name
151720951CV1396789single nucleotide variantNM_080911.3(UNG):c.399A>G (p.Gln133=)Hyper-IgM syndrome type 5 [RCV001891090]uncertain significance12109099248109099248Human1name
151744179CV1427987single nucleotide variantNM_080911.3(UNG):c.76C>T (p.Pro26Ser)Hyper-IgM syndrome type 5 [RCV001926775]uncertain significance12109097755109097755Human1name
151738520CV1437427single nucleotide variantNM_080911.3(UNG):c.62C>T (p.Ala21Val)Hyper-IgM syndrome type 5 [RCV001870777]uncertain significance12109097741109097741Human1name
151854047CV1453447single nucleotide variantNM_080911.3(UNG):c.34T>A (p.Ser12Thr)Hyper-IgM syndrome type 5 [RCV001883111]uncertain significance12109097713109097713Human1name
152162456CV1535050single nucleotide variantNM_080911.3(UNG):c.771T>C (p.Tyr257=)Hyper-IgM syndrome type 5 [RCV002141153]likely benign12109103581109103581Human1name
152161990CV1543846single nucleotide variantNM_080911.3(UNG):c.639C>T (p.Asn213=)Hyper-IgM syndrome type 5 [RCV002159801]likely benign12109103449109103449Human1name
152052535CV1607258single nucleotide variantNM_080911.3(UNG):c.696G>A (p.Glu232=)Hyper-IgM syndrome type 5 [RCV002109157]likely benign12109103506109103506Human1name
152115089CV1628159single nucleotide variantNM_080911.3(UNG):c.408C>T (p.Thr136=)Hyper-IgM syndrome type 5 [RCV002197289]likely benign12109099257109099257Human1name
152040357CV1640051single nucleotide variantNM_080911.3(UNG):c.486T>C (p.Ala162=)Hyper-IgM syndrome type 5 [RCV002087869]likely benign12109101952109101952Human1name
156379211CV1876842single nucleotide variantNM_080911.3(UNG):c.489C>T (p.His163=)Hyper-IgM syndrome type 5 [RCV003067022]likely benign12109101955109101955Human1name
155987972CV2026739single nucleotide variantNM_080911.3(UNG):c.77C>A (p.Pro26Gln)Hyper-IgM syndrome type 5 [RCV002755624]uncertain significance12109097756109097756Human1name
156100636CV2107351duplicationNM_080911.3(UNG):c.250dup (p.Arg84fs)Hyper-IgM syndrome type 5 [RCV002927038]pathogenic12109098548109098549Human1name
155993053CV2125952deletionNM_080911.3(UNG):c.162del (p.Gln55fs)Hyper-IgM syndrome type 5 [RCV002974821]pathogenic12109098459109098459Human1name
156342273CV2127678single nucleotide variantNM_080911.3(UNG):c.495C>T (p.Leu165=)Hyper-IgM syndrome type 5 [RCV002938961]likely benign12109101961109101961Human1name
155946592CV2130274single nucleotide variantNM_080911.3(UNG):c.895C>T (p.Leu299=)Hyper-IgM syndrome type 5 [RCV002971616]likely benign12109109922109109922Human1name
156052838CV2165354single nucleotide variantNM_080911.3(UNG):c.324A>G (p.Lys108=)Hyper-IgM syndrome type 5 [RCV003019456]likely benign12109098623109098623Human1name
156192723CV2171327single nucleotide variantNM_080911.3(UNG):c.924T>A (p.Ile308=)Hyper-IgM syndrome type 5 [RCV003024186]|not specified [RCV005239605]likely benign12109109951109109951Human1name
402475185CV2971855single nucleotide variantNM_080911.3(UNG):c.654T>C (p.Val218=)Hyper-IgM syndrome type 5 [RCV003625139]likely benign12109103464109103464Human1name
402471230CV3052195single nucleotide variantNM_080911.3(UNG):c.312G>C (p.Gly104=)Hyper-IgM syndrome type 5 [RCV003624191]likely benign12109098611109098611Human1name
405191476CV3118129single nucleotide variantNM_080911.3(UNG):c.303C>T (p.His101=)Hyper-IgM syndrome type 5 [RCV003821039]likely benign12109098602109098602Human1name
405184038CV3124131single nucleotide variantNM_080911.3(UNG):c.519T>C (p.Val173=)Hyper-IgM syndrome type 5 [RCV003820328]likely benign12109101985109101985Human1name
405058845CV3129369single nucleotide variantNM_080911.3(UNG):c.783G>A (p.Lys261=)Hyper-IgM syndrome type 5 [RCV003832638]likely benign12109103593109103593Human1name
11599876CV323023single nucleotide variantNM_080911.3(UNG):c.528G>A (p.Pro176=)Hyper-IgM syndrome type 5 [RCV000540196]|not provided [RCV003391079]|not specified [RCV005238878]benign|uncertain significance12109101994109101994Human1name
11605540CV323024single nucleotide variantNM_080911.3(UNG):c.660C>T (p.Ala220=)Hyper-IgM syndrome type 5 [RCV000320800]uncertain significance12109103470109103470Human1name
11623802CV330263single nucleotide variantNM_080911.3(UNG):c.759C>G (p.Leu253=)Hyper-IgM syndrome type 5 [RCV000555072]|not provided [RCV004708220]benign|likely benign12109103569109103569Human1name
597968638CV3761180single nucleotide variantNM_080911.3(UNG):c.35C>T (p.Ser12Phe)Hyper-IgM syndrome type 5 [RCV005083567]uncertain significance12109097714109097714Human1name
597937596CV3774720single nucleotide variantNM_080911.3(UNG):c.888C>G (p.Thr296=)Hyper-IgM syndrome type 5 [RCV005117753]likely benign12109109915109109915Human1name
597942268CV3779872single nucleotide variantNM_080911.3(UNG):c.858G>A (p.Gly286=)Hyper-IgM syndrome type 5 [RCV005118881]likely benign12109109885109109885Human1name
597971978CV3798963single nucleotide variantNM_080911.3(UNG):c.402C>T (p.Val134=)Hyper-IgM syndrome type 5 [RCV005142375]likely benign12109099251109099251Human1name
597914676CV3851167single nucleotide variantNM_080911.3(UNG):c.888C>T (p.Thr296=)Hyper-IgM syndrome type 5 [RCV005204135]likely benign12109109915109109915Human1name
597903282CV3851532single nucleotide variantNM_080911.3(UNG):c.558G>A (p.Leu186=)Hyper-IgM syndrome type 5 [RCV005202309]likely benign12109102863109102863Human1name
8603072CV45556single nucleotide variantNM_080911.3(UNG):c.732G>A (p.Gln244=)Hyper-IgM syndrome type 5 [RCV000030578]likely benign12109103542109103542Human1name
13821258CV565032single nucleotide variantNM_080911.3(UNG):c.651G>A (p.Thr217=)Hyper-IgM syndrome type 5 [RCV000695630]|UNG-related disorder [RCV003980314]likely benign|uncertain significance12109103461109103461Human1name , trait , alternate_id
14722367CV640589single nucleotide variantNM_080911.3(UNG):c.61G>A (p.Ala21Thr)Hyper-IgM syndrome type 5 [RCV000797528]|not specified [RCV004027600]uncertain significance12109097740109097740Human1name
15120925CV753070single nucleotide variantNM_080911.3(UNG):c.738G>A (p.Ser246=)Hyper-IgM syndrome type 5 [RCV000918396]likely benign12109103548109103548Human1name
15128913CV768874single nucleotide variantNM_080911.3(UNG):c.825G>A (p.Thr275=)Hyper-IgM syndrome type 5 [RCV001112236]likely benign|conflicting interpretations of pathogenicity|uncertain significance12109109852109109852Human1name
15121239CV784260single nucleotide variantNM_080911.3(UNG):c.819A>G (p.Leu273=)Hyper-IgM syndrome type 5 [RCV001506327]likely benign12109109846109109846Human1name
28910792CV869169single nucleotide variantNM_080911.3(UNG):c.65C>T (p.Pro22Leu)Hyper-IgM syndrome type 5 [RCV001109467]uncertain significance12109097744109097744Human1name
28910793CV869170single nucleotide variantNM_080911.3(UNG):c.86A>C (p.Gln29Pro)Hyper-IgM syndrome type 5 [RCV001109468]uncertain significance12109097765109097765Human1name
38481952CV926451single nucleotide variantNM_080911.3(UNG):c.32T>C (p.Phe11Ser)Hyper-IgM syndrome type 5 [RCV001218242]|not specified [RCV004034062]uncertain significance12109097711109097711Human1name
126744384CV1010086single nucleotide variantNM_080911.3(UNG):c.173C>T (p.Pro58Leu)Hyper-IgM syndrome type 5 [RCV001314932]|not specified [RCV004034333]uncertain significance12109098472109098472Human1name
126921664CV1047646single nucleotide variantNM_080911.3(UNG):c.155C>G (p.Pro52Arg)Hyper-IgM syndrome type 5 [RCV001363752]uncertain significance12109098454109098454Human1name
126920524CV1047647single nucleotide variantNM_080911.3(UNG):c.191C>G (p.Ser64Trp)Hyper-IgM syndrome type 5 [RCV001373856]uncertain significance12109098490109098490Human1name
126921269CV1047648single nucleotide variantNM_080911.3(UNG):c.268G>C (p.Val90Leu)Hyper-IgM syndrome type 5 [RCV001363379]|not specified [RCV004036880]uncertain significance12109098567109098567Human1name
126908867CV1047649single nucleotide variantNM_080911.3(UNG):c.271C>G (p.Pro91Ala)Hyper-IgM syndrome type 5 [RCV001368132]uncertain significance12109098570109098570Human1name
150471563CV1259140insertionNM_080911.3(UNG):c.802-48_802-47insAATnot provided [RCV001684385]benign12109109781109109782Humanname
150551980CV1300797duplicationNM_080911.3(UNG):c.799dup (p.Arg267fs)not provided [RCV001754657]uncertain significance12109103608109103609Humanname
151793555CV1420463single nucleotide variantNM_080911.3(UNG):c.110C>A (p.Pro37His)Hyper-IgM syndrome type 5 [RCV002027440]uncertain significance12109097789109097789Human1name
151834709CV1452816single nucleotide variantNM_080911.3(UNG):c.188C>T (p.Ser63Phe)Hyper-IgM syndrome type 5 [RCV001880655]uncertain significance12109098487109098487Human1name
151769842CV1460328single nucleotide variantNM_080911.3(UNG):c.200G>A (p.Ser67Asn)Hyper-IgM syndrome type 5 [RCV001863970]uncertain significance12109098499109098499Human1name
152999324CV1679764duplicationNM_080911.3(UNG):c.649dup (p.Thr217fs)Hyper-IgM syndrome type 5 [RCV002251153]pathogenic12109103458109103459Human1name
156378760CV1876745single nucleotide variantNM_080911.3(UNG):c.288G>C (p.Glu96Asp)Hyper-IgM syndrome type 5 [RCV003066976]uncertain significance12109098587109098587Human1name
156203220CV2021319single nucleotide variantNM_080911.3(UNG):c.134C>T (p.Ala45Val)Hyper-IgM syndrome type 5 [RCV002711475]uncertain significance12109098433109098433Human1name
156138495CV2177715single nucleotide variantNM_080911.3(UNG):c.263G>C (p.Arg88Pro)Hyper-IgM syndrome type 5 [RCV003039952]uncertain significance12109098562109098562Human1name
8563029CV27329deletionNM_080911.3(UNG):c.392del (p.Pro131fs)Hyper-IgM syndrome type 5 [RCV000013084]pathogenic12109099237109099237Human1name
11651608CV323018single nucleotide variantNM_080911.3(UNG):c.100G>A (p.Ala34Thr)Hyper-IgM syndrome type 5 [RCV000299867]uncertain significance12109097779109097779Human1name
11620074CV329054single nucleotide variantNM_080911.3(UNG):c.231C>G (p.Asn77Lys)Hyper-IgM syndrome type 5 [RCV000332287]uncertain significance12109098530109098530Human1name
405810159CV3345141single nucleotide variantNM_080911.3(UNG):c.266A>G (p.Asn89Ser)not specified [RCV004482101]uncertain significance12109098565109098565Humanname
597670043CV3707108single nucleotide variantNM_080911.3(UNG):c.294G>A (p.Trp98Ter)Hyper-IgM syndrome type 5 [RCV005004784]likely pathogenic12109098593109098593Human1name
597906009CV3785145deletionNM_080911.3(UNG):c.682del (p.Glu228fs)Hyper-IgM syndrome type 5 [RCV005127988]pathogenic12109103491109103491Human1name
597941504CV3785809deletionNM_080911.3(UNG):c.348del (p.Phe117fs)Hyper-IgM syndrome type 5 [RCV005133702]pathogenic12109099197109099197Human1name
598127559CV3882739single nucleotide variantNM_080911.3(UNG):c.114G>C (p.Glu38Asp)Hyper-IgM syndrome type 5 [RCV005234270]uncertain significance12109097793109097793Human1name
13436302CV434025single nucleotide variantNM_080911.3(UNG):c.262C>T (p.Arg88Cys)Hyper-IgM syndrome type 5 [RCV000687269]|not provided [RCV000506946]conflicting interpretations of pathogenicity|uncertain significance12109098561109098561Human1name
13482118CV461582single nucleotide variantNM_080911.3(UNG):c.146A>G (p.Lys49Arg)Hyper-IgM syndrome type 5 [RCV000551728]likely benign|uncertain significance12109098445109098445Human1name
13607327CV526630single nucleotide variantNM_080911.3(UNG):c.265A>G (p.Asn89Asp)Hyper-IgM syndrome type 5 [RCV000639383]uncertain significance12109098564109098564Human1name
13706069CV537209deletionNM_080911.3(UNG):c.309del (p.Ser103fs)not provided [RCV000658665]likely pathogenic12109098608109098608Humanname
14730095CV640590single nucleotide variantNM_080911.3(UNG):c.260C>T (p.Ala87Val)Hyper-IgM syndrome type 5 [RCV000800808]uncertain significance12109098559109098559Human1name
15165642CV724868single nucleotide variantNM_080911.3(UNG):c.194C>T (p.Pro65Leu)Hyper-IgM syndrome type 5 [RCV001109469]likely benign|conflicting interpretations of pathogenicity|uncertain significance12109098493109098493Human1name
38482155CV926452single nucleotide variantNM_080911.3(UNG):c.124G>C (p.Asp42His)Hyper-IgM syndrome type 5 [RCV001218333]uncertain significance12109097803109097803Human1name
126908721CV969946single nucleotide variantNM_080911.3(UNG):c.289A>T (p.Ser97Cys)Hereditary breast ovarian cancer syndrome [RCV001374544]uncertain significance12109098588109098588Human1name
126750439CV994876single nucleotide variantNM_080911.3(UNG):c.232A>G (p.Lys78Glu)Hyper-IgM syndrome type 5 [RCV001297320]uncertain significance12109098531109098531Human1name
126766033CV1010087duplicationNM_080911.3(UNG):c.891dup (p.Glu298Ter)Hyper-IgM syndrome type 5 [RCV001320279]uncertain significance12109109917109109918Human1name
126741103CV1017555single nucleotide variantNM_080911.3(UNG):c.490G>A (p.Gly164Arg)Hyper-IgM syndrome type 5 [RCV001329608]uncertain significance12109101956109101956Human1name
126730522CV1020971single nucleotide variantNM_080911.3(UNG):c.710C>G (p.Ala237Gly)Hyper-IgM syndrome type 5 [RCV001333460]uncertain significance12109103520109103520Human1name
126911124CV1047650single nucleotide variantNM_080911.3(UNG):c.524C>T (p.Pro175Leu)Hyper-IgM syndrome type 5 [RCV001369081]uncertain significance12109101990109101990Human1name
126914449CV1047651single nucleotide variantNM_080911.3(UNG):c.548A>G (p.Tyr183Cys)Hyper-IgM syndrome type 5 [RCV001370477]uncertain significance12109102853109102853Human1name
126912670CV1047652single nucleotide variantNM_080911.3(UNG):c.721T>C (p.Trp241Arg)Hyper-IgM syndrome type 5 [RCV001369820]uncertain significance12109103531109103531Human1name
126918368CV1047653single nucleotide variantNM_080911.3(UNG):c.796G>C (p.Asp266His)Hyper-IgM syndrome type 5 [RCV001372619]uncertain significance12109103606109103606Human1name
127263603CV1062570single nucleotide variantNM_080911.3(UNG):c.730C>T (p.Gln244Ter)Hyper-IgM syndrome type 5 [RCV001387995]pathogenic12109103540109103540Human1name
150477620CV1279484insertionNM_080911.3(UNG):c.802-48_802-47insAAATnot provided [RCV001714157]benign12109109781109109782Humanname
151878791CV1370164single nucleotide variantNM_080911.3(UNG):c.934G>A (p.Glu312Lys)Hyper-IgM syndrome type 5 [RCV001961376]uncertain significance12109109961109109961Human1name
151852399CV1378854single nucleotide variantNM_080911.3(UNG):c.514C>G (p.Pro172Ala)Hyper-IgM syndrome type 5 [RCV001882920]|not specified [RCV004040602]uncertain significance12109101980109101980Human1name
151864884CV1380784single nucleotide variantNM_080911.3(UNG):c.523C>G (p.Pro175Ala)Hyper-IgM syndrome type 5 [RCV002018215]uncertain significance12109101989109101989Human1name
151814273CV1382324single nucleotide variantNM_080911.3(UNG):c.586C>T (p.Pro196Ser)Hyper-IgM syndrome type 5 [RCV001992130]uncertain significance12109102891109102891Human1name
151808608CV1383984single nucleotide variantNM_080911.3(UNG):c.371A>G (p.His124Arg)Hyper-IgM syndrome type 5 [RCV001878039]uncertain significance12109099220109099220Human1name
151765463CV1387514single nucleotide variantNM_080911.3(UNG):c.489C>G (p.His163Gln)Hyper-IgM syndrome type 5 [RCV001987731]uncertain significance12109101955109101955Human1name
151838950CV1415142single nucleotide variantNM_080911.3(UNG):c.851A>G (p.Tyr284Cys)Hyper-IgM syndrome type 5 [RCV001921299]uncertain significance12109109878109109878Human1name
151729659CV1416606single nucleotide variantNM_080911.3(UNG):c.399A>C (p.Gln133His)Hyper-IgM syndrome type 5 [RCV002004636]|not specified [RCV004043926]uncertain significance12109099248109099248Human1name
151793621CV1420472single nucleotide variantNM_080911.3(UNG):c.686G>A (p.Arg229Gln)Hyper-IgM syndrome type 5 [RCV002027446]uncertain significance12109103496109103496Human1name
151839366CV1492893single nucleotide variantNM_080911.3(UNG):c.583C>A (p.His195Asn)Hyper-IgM syndrome type 5 [RCV001881156]uncertain significance12109102888109102888Human1name
151773895CV1504903single nucleotide variantNM_080911.3(UNG):c.541A>G (p.Asn181Asp)Hyper-IgM syndrome type 5 [RCV002009107]uncertain significance12109102846109102846Human1name
156386897CV1875084single nucleotide variantNM_080911.3(UNG):c.674C>T (p.Ser225Phe)Hyper-IgM syndrome type 5 [RCV003050936]uncertain significance12109103484109103484Human1name
156183392CV1884795single nucleotide variantNM_080911.3(UNG):c.580G>A (p.Val194Ile)Hyper-IgM syndrome type 5 [RCV003083635]uncertain significance12109102885109102885Human1name
155952607CV1896334single nucleotide variantNM_080911.3(UNG):c.487C>T (p.His163Tyr)Hyper-IgM syndrome type 5 [RCV003095415]uncertain significance12109101953109101953Human1name
156137991CV1902239single nucleotide variantNM_080911.3(UNG):c.527C>T (p.Pro176Leu)Hyper-IgM syndrome type 5 [RCV003082091]uncertain significance12109101993109101993Human1name
155984812CV1907472single nucleotide variantNM_080911.3(UNG):c.579T>G (p.Phe193Leu)Hyper-IgM syndrome type 5 [RCV003097552]benign12109102884109102884Human1name
156415454CV1958508single nucleotide variantNM_080911.3(UNG):c.631C>T (p.Leu211Phe)Hyper-IgM syndrome type 5 [RCV002589179]uncertain significance12109103441109103441Human1name
156072703CV2015541single nucleotide variantNM_080911.3(UNG):c.640G>A (p.Ala214Thr)Hyper-IgM syndrome type 5 [RCV002705733]uncertain significance12109103450109103450Human1name
156182741CV2020549single nucleotide variantNM_080911.3(UNG):c.634C>G (p.Leu212Val)Hyper-IgM syndrome type 5 [RCV002710833]uncertain significance12109103444109103444Human1name
156347470CV2051984single nucleotide variantNM_080911.3(UNG):c.489C>A (p.His163Gln)Hyper-IgM syndrome type 5 [RCV002811541]uncertain significance12109101955109101955Human1name
156130541CV2114825single nucleotide variantNM_080911.3(UNG):c.521C>T (p.Pro174Leu)Hyper-IgM syndrome type 5 [RCV002914535]|not specified [RCV004066281]uncertain significance12109101987109101987Human1name
155942609CV2115047single nucleotide variantNM_080911.3(UNG):c.388C>A (p.Pro130Thr)Hyper-IgM syndrome type 5 [RCV002904575]uncertain significance12109099237109099237Human1name
156008787CV2127561single nucleotide variantNM_080911.3(UNG):c.824C>G (p.Thr275Arg)Hyper-IgM syndrome type 5 [RCV002948149]uncertain significance12109109851109109851Human1name
155976972CV2151239single nucleotide variantNM_080911.3(UNG):c.737C>T (p.Ser246Leu)Hyper-IgM syndrome type 5 [RCV003033696]uncertain significance12109103547109103547Human1name
155963349CV2282730single nucleotide variantNM_080911.3(UNG):c.389C>T (p.Pro130Leu)not specified [RCV004141592]uncertain significance12109099238109099238Humanname
156179399CV2298375single nucleotide variantNM_080911.3(UNG):c.442G>T (p.Val148Phe)not specified [RCV004160266]uncertain significance12109101908109101908Humanname
401724871CV2672329single nucleotide variantNM_080911.3(UNG):c.339G>T (p.Lys113Asn)not provided [RCV003239230]uncertain significance12109098638109098638Humanname
8598963CV27331single nucleotide variantNM_080911.3(UNG):c.752T>C (p.Phe251Ser)Hyper-IgM syndrome type 5 [RCV000013086]pathogenic12109103562109103562Human1name
404991684CV2856437single nucleotide variantNM_080911.3(UNG):c.925G>A (p.Asp309Asn)Hyper-IgM syndrome type 5 [RCV003512882]uncertain significance12109109952109109952Human1name
404994516CV2869865single nucleotide variantNM_080911.3(UNG):c.437T>G (p.Val146Gly)Hyper-IgM syndrome type 5 [RCV003513225]uncertain significance12109101903109101903Human1name
11610609CV315877single nucleotide variantNM_080911.3(UNG):c.544A>G (p.Ile182Val)Hyper-IgM syndrome type 5 [RCV000791786]uncertain significance12109102849109102849Human1name
11615395CV329061single nucleotide variantNM_080911.3(UNG):c.769T>C (p.Tyr257His)Hyper-IgM syndrome type 5 [RCV000285151]|not provided [RCV000520946]|not specified [RCV004021531]uncertain significance12109103579109103579Human1name
407454782CV3489385single nucleotide variantNM_080911.3(UNG):c.338A>G (p.Lys113Arg)not specified [RCV004685230]uncertain significance12109098637109098637Humanname
407454785CV3489386single nucleotide variantNM_080911.3(UNG):c.488A>G (p.His163Arg)not specified [RCV004685231]uncertain significance12109101954109101954Humanname
408388692CV3522699single nucleotide variantNM_080911.3(UNG):c.313G>T (p.Glu105Ter)Hyper-IgM syndrome type 5 [RCV005104946]|not provided [RCV004769080]pathogenic|uncertain significance12109098612109098612Human1name
597670052CV3707109single nucleotide variantNM_080911.3(UNG):c.454G>T (p.Gly152Ter)Hyper-IgM syndrome type 5 [RCV005004785]likely pathogenic12109101920109101920Human1name
597914457CV3778885single nucleotide variantNM_080911.3(UNG):c.570A>G (p.Ile190Met)Hyper-IgM syndrome type 5 [RCV005129230]uncertain significance12109102875109102875Human1name
597941544CV3785817single nucleotide variantNM_080911.3(UNG):c.343A>T (p.Met115Leu)Hyper-IgM syndrome type 5 [RCV005133710]uncertain significance12109099192109099192Human1name
597900883CV3796625single nucleotide variantNM_080911.3(UNG):c.514C>A (p.Pro172Thr)Hyper-IgM syndrome type 5 [RCV005152707]uncertain significance12109101980109101980Human1name
598191409CV3925715single nucleotide variantNM_080911.3(UNG):c.880T>A (p.Ser294Thr)not specified [RCV005288354]uncertain significance12109109907109109907Humanname
13490009CV461584single nucleotide variantNM_080911.3(UNG):c.843G>T (p.Leu281Phe)Hyper-IgM syndrome type 5 [RCV000533213]|not provided [RCV003884610]likely benign12109109870109109870Human1name
13607331CV526638single nucleotide variantNM_080911.3(UNG):c.911G>A (p.Gly304Asp)Hyper-IgM syndrome type 5 [RCV000639384]uncertain significance12109109938109109938Human1name
13814511CV571181single nucleotide variantNM_080911.3(UNG):c.392C>T (p.Pro131Leu)Hyper-IgM syndrome type 5 [RCV000705084]likely benign|uncertain significance12109099241109099241Human1name
13807872CV571184single nucleotide variantNM_080911.3(UNG):c.685C>T (p.Arg229Ter)Hyper-IgM syndrome type 5 [RCV000701366]pathogenic12109103495109103495Human1name
14703677CV640591single nucleotide variantNM_080911.3(UNG):c.366A>C (p.Arg122Ser)Hyper-IgM syndrome type 5 [RCV000807482]|not specified [RCV004028615]uncertain significance12109099215109099215Human1name
14736687CV640592single nucleotide variantNM_080911.3(UNG):c.593A>G (p.His198Arg)Hyper-IgM syndrome type 5 [RCV000803713]|not specified [RCV001192880]uncertain significance12109102898109102898Human1name
14735442CV640593single nucleotide variantNM_080911.3(UNG):c.805C>T (p.Arg269Trp)Hyper-IgM syndrome type 5 [RCV000803154]uncertain significance12109109832109109832Human1name
21074319CV796681duplicationNM_080911.3(UNG):c.501dup (p.Ser168Ter)not provided [RCV000994969]uncertain significance12109101964109101965Humanname
28868076CV869171single nucleotide variantNM_080911.3(UNG):c.664C>G (p.Gln222Glu)Hyper-IgM syndrome type 5 [RCV001112234]uncertain significance12109103474109103474Human1name
28868079CV869172single nucleotide variantNM_080911.3(UNG):c.812A>G (p.His271Arg)Hyper-IgM syndrome type 5 [RCV001112235]uncertain significance12109109839109109839Human1name
38477758CV926453single nucleotide variantNM_080911.3(UNG):c.318C>A (p.Phe106Leu)Hyper-IgM syndrome type 5 [RCV001216290]uncertain significance12109098617109098617Human1name
38479631CV926454single nucleotide variantNM_080911.3(UNG):c.638A>G (p.Asn213Ser)Hyper-IgM syndrome type 5 [RCV001217087]uncertain significance12109103448109103448Human1name
38487157CV926455single nucleotide variantNM_080911.3(UNG):c.839C>T (p.Pro280Leu)Hyper-IgM syndrome type 5 [RCV001220635]uncertain significance12109109866109109866Human1name
38481871CV947771single nucleotide variantNM_080911.3(UNG):c.415C>A (p.Gln139Lys)Hyper-IgM syndrome type 5 [RCV001235322]uncertain significance12109099264109099264Human1name
38483730CV947772single nucleotide variantNM_080911.3(UNG):c.631C>A (p.Leu211Ile)Hyper-IgM syndrome type 5 [RCV001236044]uncertain significance12109103441109103441Human1name
38456213CV947773single nucleotide variantNM_080911.3(UNG):c.653T>G (p.Val218Gly)Hyper-IgM syndrome type 5 [RCV001228277]uncertain significance12109103463109103463Human1name
38486913CV947774single nucleotide variantNM_080911.3(UNG):c.824C>T (p.Thr275Met)Hyper-IgM syndrome type 5 [RCV001237357]uncertain significance12109109851109109851Human1name
38498500CV956739single nucleotide variantNM_080911.3(UNG):c.868T>G (p.Cys290Gly)Hyper-IgM syndrome type 5 [RCV001243867]uncertain significance12109109895109109895Human1name
126734576CV994877single nucleotide variantNM_080911.3(UNG):c.452T>C (p.Leu151Pro)Hyper-IgM syndrome type 5 [RCV001294940]uncertain significance12109101918109101918Human1name
126752561CV994878single nucleotide variantNM_080911.3(UNG):c.487C>G (p.His163Asp)Hyper-IgM syndrome type 5 [RCV001297755]|not specified [RCV004036082]uncertain significance12109101953109101953Human1name
126761728CV994879single nucleotide variantNM_080911.3(UNG):c.508C>G (p.Gln170Glu)Hyper-IgM syndrome type 5 [RCV001300180]uncertain significance12109101974109101974Human1name
126762372CV994880single nucleotide variantNM_080911.3(UNG):c.620A>G (p.Gln207Arg)Hyper-IgM syndrome type 5 [RCV001300374]uncertain significance12109102925109102925Human1name
150450059CV1254063insertionNM_080911.3(UNG):c.802-48_802-47insAAAATnot provided [RCV001667700]benign12109109781109109782Humanname
150545442CV1315590deletionNM_080911.3(UNG):c.569_570del (p.Ile190fs)Hyper-IgM syndrome type 5 [RCV003513623]pathogenic|likely pathogenic12109102873109102874Human1name
151839656CV1364271microsatelliteNM_080911.3(UNG):c.366_369del (p.Arg122fs)Hyper-IgM syndrome type 5 [RCV001994580]pathogenic12109099208109099211Humanname
151794905CV1420627microsatelliteNM_080911.3(UNG):c.778AAG[1] (p.Lys261del)Hyper-IgM syndrome type 5 [RCV002027562]uncertain significance12109103586109103588Humanname
8563030CV27330microsatelliteNM_080911.3(UNG):c.572_573del (p.Glu191fs)Hyper-IgM syndrome type 5 [RCV000013085]pathogenic12109102875109102876Humanname
8563031CV27332deletionNM_080911.3(UNG):c.428_429del (p.Ile143fs)Hyper-IgM syndrome type 5 [RCV000013087]pathogenic12109099276109099277Human1name
597670061CV3707110deletionNM_080911.3(UNG):c.551_552del (p.Lys184fs)Hyper-IgM syndrome type 5 [RCV005004786]likely pathogenic12109102855109102856Human1name
151829737CV1465901deletionNM_080911.3(UNG):c.47_73del (p.Ala16_Pro24del)Hyper-IgM syndrome type 5 [RCV002050605]uncertain significance12109097714109097740Human1name
126908917CV1052897deletionNM_080911.3(UNG):c.294del (p.Ser97_Trp98insTer)Hyper-IgM syndrome type 5 [RCV001374665]pathogenic12109098592109098592Human1name
26901103CV839253indelNM_080911.3(UNG):c.178_182delinsCAGGAGGA (p.Thr60_Pro61delinsGlnGluGlu)Hyper-IgM syndrome type 5 [RCV001055860]uncertain significance12109098477109098481Humanname
9589507CV165961single nucleotide variantNM_015278.5(SASH1):c.1849G>A (p.Glu617Lys)Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma [RCV000766196]|Palmoplantar keratoderma [RCV000144361]pathogenic|likely pathogenic6148533885148533885Human4alternate_id
126765874CV1025142single nucleotide variantNM_003722.5(TP63):c.1121C>T (p.Thr374Met)ADULT syndrome [RCV002486385]|TP63-Related Spectrum Disorders [RCV001342203]uncertain significance3189868708189868708Human9alternate_id
126773774CV1025143single nucleotide variantNM_003722.5(TP63):c.1697C>T (p.Thr566Met)ADULT syndrome [RCV002493783]|ADULT syndrome [RCV005394964]|TP63-Related Spectrum Disorders [RCV001346460]uncertain significance3189890833189890833Human10alternate_id
126919893CV1042089single nucleotide variantNM_003722.5(TP63):c.799G>A (p.Val267Ile)ADULT syndrome [RCV003333764]|TP63-Related Spectrum Disorders [RCV001362555]uncertain significance3189866714189866714Human1alternate_id
127271285CV1059703single nucleotide variantNM_003722.5(TP63):c.1670G>T (p.Gly557Val)ADULT syndrome [RCV003136064]|TP63-Related Spectrum Disorders [RCV001390109]pathogenic|likely pathogenic3189890806189890806Human1alternate_id
127250186CV1092295single nucleotide variantNM_003722.5(TP63):c.1626G>A (p.Pro542=)ADULT syndrome [RCV002488244]|TP63-Related Spectrum Disorders [RCV001436269]|TP63-related disorder [RCV003938759]likely benign3189889458189889458Human9alternate_id
150550837CV1305253single nucleotide variantNM_003722.5(TP63):c.2021G>A (p.Arg674His)ADULT syndrome [RCV002488602]|not provided [RCV001766033]|not specified [RCV003331198]uncertain significance3189894480189894480Human1alternate_id
151348570CV1324098single nucleotide variantNM_003722.5(TP63):c.802G>A (p.Glu268Lys)ADULT syndrome [RCV003154197]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV001808011]likely pathogenic|uncertain significance3189866717189866717Human2alternate_id
151853375CV1349257single nucleotide variantNM_003722.5(TP63):c.1814G>A (p.Arg605Gln)ADULT syndrome [RCV002484467]|TP63-Related Spectrum Disorders [RCV001923091]|not provided [RCV002272528]benign|uncertain significance3189894273189894273Human9alternate_id
151814983CV1349905single nucleotide variantNM_003722.5(TP63):c.1612A>G (p.Thr538Ala)ADULT syndrome [RCV002486578]|TP63-Related Spectrum Disorders [RCV002012813]uncertain significance3189889444189889444Human9alternate_id
151885063CV1364252single nucleotide variantNM_003722.5(TP63):c.1095G>A (p.Ser365=)ADULT syndrome [RCV002497866]|TP63-Related Spectrum Disorders [RCV002037680]likely benign3189868682189868682Human9alternate_id
151874204CV1369448single nucleotide variantNM_003722.5(TP63):c.1394C>T (p.Pro465Leu)ADULT syndrome [RCV002479821]|TP63-Related Spectrum Disorders [RCV002036054]uncertain significance3189886438189886438Human9alternate_id
151744388CV1404678single nucleotide variantNM_003722.5(TP63):c.1352C>G (p.Thr451Ser)ADULT syndrome [RCV002479739]|TP63-Related Spectrum Disorders [RCV002022652]likely benign|uncertain significance3189886396189886396Human9alternate_id
151793304CV1423061single nucleotide variantNM_003722.5(TP63):c.50C>G (p.Pro17Arg)ADULT syndrome [RCV002479438]|TP63-Related Spectrum Disorders [RCV001917025]uncertain significance3189631565189631565Human9alternate_id
151841883CV1423847single nucleotide variantNM_003722.5(TP63):c.2003G>A (p.Arg668His)ADULT syndrome [RCV002507738]|TP63-Related Spectrum Disorders [RCV001977796]likely benign|uncertain significance3189894462189894462Human9alternate_id
151799806CV1430725microsatelliteNM_003722.5(TP63):c.1831TCC[1] (p.Ser612del)ADULT syndrome [RCV002482573]|TP63-Related Spectrum Disorders [RCV001877272]uncertain significance3189894289189894291Humanalternate_id
151774305CV1430865single nucleotide variantNM_003722.5(TP63):c.1537G>C (p.Ala513Pro)ADULT syndrome [RCV005023331]|TP63-Related Spectrum Disorders [RCV001864370]benign|uncertain significance3189889369189889369Human10alternate_id
151849384CV1431343single nucleotide variantNM_003722.5(TP63):c.110G>A (p.Arg37Gln)ADULT syndrome [RCV002482760]|TP63-Related Spectrum Disorders [RCV001922562]uncertain significance3189737787189737787Human9alternate_id
151777826CV1436728single nucleotide variantNM_003722.5(TP63):c.1570G>A (p.Ala524Thr)ADULT syndrome [RCV002466729]|TP63-Related Spectrum Disorders [RCV001971798]uncertain significance3189889402189889402Human1alternate_id
151800604CV1442183single nucleotide variantNM_003722.5(TP63):c.62G>A (p.Arg21His)ADULT syndrome [RCV002479771]|TP63-Related Spectrum Disorders [RCV002011531]|not provided [RCV004697185]uncertain significance3189631577189631577Human9alternate_id
151667729CV1460838single nucleotide variantNM_003722.5(TP63):c.1583C>A (p.Pro528Gln)ADULT syndrome [RCV005038437]|TP63-Related Spectrum Disorders [RCV001888941]|not provided [RCV002508326]uncertain significance3189889415189889415Human10alternate_id
151856688CV1470088microsatelliteNM_003722.5(TP63):c.1507+6_1507+7delADULT syndrome [RCV005023350]|TP63-Related Spectrum Disorders [RCV001883415]uncertain significance3189886555189886556Humanalternate_id
151878707CV1493932single nucleotide variantNM_003722.5(TP63):c.1807G>C (p.Asp603His)ADULT syndrome [RCV005002692]|TP63-Related Spectrum Disorders [RCV001982230]|TP63-related disorder [RCV004746523]likely benign|uncertain significance3189894266189894266Human10alternate_id
151810559CV1497405single nucleotide variantNM_003722.5(TP63):c.882+19A>TADULT syndrome [RCV002503666]|TP63-Related Spectrum Disorders [RCV001974726]likely benign3189866816189866816Human9alternate_id
152058632CV1531940single nucleotide variantNM_003722.5(TP63):c.498C>T (p.Pro166=)ADULT syndrome [RCV002494016]|TP63-Related Spectrum Disorders [RCV002089997]benign|likely benign3189808445189808445Human9alternate_id
152049809CV1540384single nucleotide variantNM_003722.5(TP63):c.654A>G (p.Pro218=)ADULT syndrome [RCV002494367]|TP63-Related Spectrum Disorders [RCV002108809]likely benign3189864306189864306Human9alternate_id
152030112CV1570681single nucleotide variantNM_003722.5(TP63):c.156A>G (p.Pro52=)ADULT syndrome [RCV002500006]|TP63-Related Spectrum Disorders [RCV002105821]|TP63-related disorder [RCV004747045]likely benign3189737833189737833Human9alternate_id
152034565CV1610617single nucleotide variantNM_003722.5(TP63):c.20G>T (p.Arg7Leu)ADULT syndrome [RCV002480958]|TP63-Related Spectrum Disorders [RCV002125117]|TP63-related disorder [RCV003913742]benign|likely benign3189631535189631535Human9alternate_id
152156613CV1630419single nucleotide variantNM_003722.5(TP63):c.1367C>T (p.Pro456Leu)ADULT syndrome [RCV005025708]|TP63-Related Spectrum Disorders [RCV002122523]|not provided [RCV002464516]benign|uncertain significance3189886411189886411Human10alternate_id
152082144CV1641473single nucleotide variantNM_003722.5(TP63):c.475C>T (p.Leu159Phe)ADULT syndrome [RCV005025689]|TP63-Related Spectrum Disorders [RCV002211558]likely benign3189808422189808422Human10alternate_id
152103002CV1656672single nucleotide variantNM_003722.5(TP63):c.1575C>T (p.Leu525=)ADULT syndrome [RCV002507993]|TP63-Related Spectrum Disorders [RCV002115592]likely benign3189889407189889407Human9alternate_id
152091800CV1662273single nucleotide variantNM_003722.5(TP63):c.1480A>G (p.Thr494Ala)ADULT syndrome [RCV005025709]|TP63-Related Spectrum Disorders [RCV002132136]benign|uncertain significance3189886524189886524Human10alternate_id
156243495CV1893882single nucleotide variantNM_003722.5(TP63):c.1861A>G (p.Ser621Gly)ADULT syndrome [RCV005028202]|TP63-Related Spectrum Disorders [RCV003085834]uncertain significance3189894320189894320Human10alternate_id
155935080CV1916343single nucleotide variantNM_003722.5(TP63):c.1518G>A (p.Met506Ile)ADULT syndrome [RCV005034735]|TP63-Related Spectrum Disorders [RCV002615244]uncertain significance3189889350189889350Human10alternate_id
10048503CV193526deletionNM_003722.5(TP63):c.192-9_192-8delADULT syndrome [RCV002503681]|TP63-Related Spectrum Disorders [RCV001080338]|not provided [RCV000514456]|not specified [RCV000177177]benign|likely benign3189738632189738633Human9alternate_id
156445331CV1945338single nucleotide variantNM_003722.5(TP63):c.2040G>C (p.Glu680Asp)ADULT syndrome [RCV005029906]|TP63-Related Spectrum Disorders [RCV003116272]uncertain significance3189894499189894499Human10alternate_id
156404778CV1993507single nucleotide variantNM_003722.5(TP63):c.1594C>G (p.Pro532Ala)ADULT syndrome [RCV005025921]|TP63-Related Spectrum Disorders [RCV002658136]uncertain significance3189889426189889426Human10alternate_id
10408567CV204361deletionNM_003722.5(TP63):c.1963del (p.Arg655fs)ADULT syndrome [RCV000195096]pathogenic3189894419189894419Humanalternate_id
156103729CV2096311single nucleotide variantNM_003722.5(TP63):c.1481C>T (p.Thr494Ile)ADULT syndrome [RCV005028014]|TP63-Related Spectrum Disorders [RCV002913503]uncertain significance3189886525189886525Human10alternate_id
8559391CV21566single nucleotide variantNM_003722.5(TP63):c.727C>T (p.Arg243Trp)ADULT syndrome [RCV005025017]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV000006900]|Rapp-Hodgkin syndrome [RCV002283440]|TP63-Related Spectrum Disorders [RCV000812084]|not provided [RCV000394306]pathogenic3189864379189864379Human10alternate_id
8559398CV21573single nucleotide variantNM_003722.5(TP63):c.1028G>A (p.Arg343Gln)ADULT syndrome [RCV005025018]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV000006908]|Inborn genetic diseases [RCV001266717]|TP63-Related Spectrum Disorders [RCV000655484]|not provided [RCV000276670]pathogenic|likely pathogenic3189868615189868615Human11alternate_id
8559401CV21576single nucleotide variantNM_001114980.2(TP63):c.16A>C (p.Asn6His)ADULT syndrome [RCV000006911]pathogenic3189789816189789816Human1alternate_id
8559404CV21579single nucleotide variantNM_003722.5(TP63):c.1010G>A (p.Arg337Gln)ADULT syndrome [RCV000006914]|TP63-Related Spectrum Disorders [RCV000794231]|not provided [RCV001781195]pathogenic|likely pathogenic3189868597189868597Human1alternate_id
8559410CV21585single nucleotide variantTP63, VAL114METADULT syndrome [RCV000006921]pathogenicHuman1alternate_id
8559412CV21587single nucleotide variantNM_003722.5(TP63):c.1009C>G (p.Arg337Gly)ADULT syndrome [RCV000006923]|not provided [RCV001280741]pathogenic3189868596189868596Human1alternate_id
8559413CV21588single nucleotide variantNM_003722.5(TP63):c.289C>T (p.Arg97Cys)ADULT syndrome [RCV005031401]|Split hand-foot malformation 4 [RCV000006924]|TP63-Related Spectrum Disorders [RCV001851711]pathogenic|uncertain significance3189738739189738739Human10alternate_id
8559414CV21589single nucleotide variantNM_003722.5(TP63):c.797G>A (p.Arg266Gln)ADULT syndrome [RCV000006926]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV000006925]|TP63-Related Spectrum Disorders [RCV001390108]|not provided [RCV000413620]pathogenic|likely pathogenic3189866712189866712Human3alternate_id
8559416CV21591single nucleotide variantP127LADULT syndrome [RCV000006928]pathogenicHuman1alternate_id
156439983CV2401667single nucleotide variantNM_003722.5(TP63):c.19C>T (p.Arg7Trp)ADULT syndrome [RCV005036644]|TP63-Related Spectrum Disorders [RCV003757247]|not provided [RCV003109955]uncertain significance3189631534189631534Human10alternate_id
11579142CV271227single nucleotide variantNM_003722.5(TP63):c.1531C>A (p.Pro511Thr)ADULT syndrome [RCV002480032]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV000296599]|Orofacial cleft 8 [RCV000399267]|TP63-Related Spectrum Disorders [RCV000351504]|not provided [RCV001572958]|not specified [RCV000384210]benign|likely benign3189889363189889363Human9alternate_id
401937844CV2797181single nucleotide variantNM_003722.5(TP63):c.122C>T (p.Ser41Phe)ADULT syndrome [RCV005036783]|TP63-Related Spectrum Disorders [RCV005062890]|TP63-related disorder [RCV003416940]|not provided [RCV005228029]uncertain significance3189737799189737799Human10alternate_id
405051637CV2887732single nucleotide variantNM_003722.5(TP63):c.1661C>T (p.Ala554Val)ADULT syndrome [RCV005030092]|TP63-Related Spectrum Disorders [RCV003592908]likely benign|uncertain significance3189890797189890797Human10alternate_id
11585921CV294095single nucleotide variantNM_003722.5(TP63):c.992+4A>CADULT syndrome [RCV002502321]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV000283959]|Orofacial cleft 8 [RCV000321352]|TP63-Related Spectrum Disorders [RCV000378424]|not provided [RCV001618612]benign|likely benign3189867946189867946Human9alternate_id
405167746CV3031152single nucleotide variantNM_003722.5(TP63):c.362A>G (p.Asp121Gly)ADULT syndrome [RCV005030203]|TP63-Related Spectrum Disorders [RCV003757890]pathogenic|uncertain significance3189808309189808309Human10alternate_id
405154965CV3054728single nucleotide variantNM_003722.5(TP63):c.1223G>A (p.Arg408His)ADULT syndrome [RCV005030227]|TP63-Related Spectrum Disorders [RCV003756675]uncertain significance3189872869189872869Human10alternate_id
405160213CV3076485single nucleotide variantNM_003722.5(TP63):c.1898C>G (p.Thr633Ser)ADULT syndrome [RCV005392690]|Inborn genetic diseases [RCV004968444]|TP63-Related Spectrum Disorders [RCV003757122]uncertain significance3189894357189894357Human9alternate_id
405199905CV3128867single nucleotide variantNM_003722.5(TP63):c.1142A>G (p.Asn381Ser)ADULT syndrome [RCV005038545]|TP63-Related Spectrum Disorders [RCV003821910]uncertain significance3189869336189869336Human10alternate_id
597716283CV3717395single nucleotide variantNM_003722.5(TP63):c.131C>A (p.Thr44Lys)ADULT syndrome [RCV005035284]uncertain significance3189737808189737808Human1alternate_id
597637849CV3717396single nucleotide variantNM_003722.5(TP63):c.161T>C (p.Val54Ala)ADULT syndrome [RCV005024551]uncertain significance3189737838189737838Human1alternate_id
597716303CV3717397single nucleotide variantNM_003722.5(TP63):c.325-18411A>GADULT syndrome [RCV005035286]uncertain significance3189789861189789861Human1alternate_id
597637856CV3717398duplicationNM_003722.5(TP63):c.345dup (p.Leu116fs)ADULT syndrome [RCV005024552]likely pathogenic3189808288189808289Human1alternate_id
597637862CV3717400single nucleotide variantNM_003722.5(TP63):c.543C>G (p.Phe181Leu)ADULT syndrome [RCV005024553]uncertain significance3189808490189808490Human1alternate_id
597637868CV3717401single nucleotide variantNM_003722.5(TP63):c.609C>T (p.Cys203=)ADULT syndrome [RCV005024554]uncertain significance3189864261189864261Human1alternate_id
597637875CV3717402single nucleotide variantNM_003722.5(TP63):c.809A>G (p.Asn270Ser)ADULT syndrome [RCV005024555]uncertain significance3189866724189866724Human1alternate_id
597637880CV3717403single nucleotide variantNM_003722.5(TP63):c.1129+1G>AADULT syndrome [RCV005024556]likely pathogenic3189868717189868717Human1alternate_id
597716315CV3717404single nucleotide variantNM_003722.5(TP63):c.1160T>A (p.Met387Lys)ADULT syndrome [RCV005035287]uncertain significance3189869354189869354Human1alternate_id
597716323CV3717405single nucleotide variantNM_003722.5(TP63):c.1350-6263G>AADULT syndrome [RCV005035288]uncertain significance3189880131189880131Human1alternate_id
597637887CV3717406single nucleotide variantNM_003722.5(TP63):c.1350-7T>AADULT syndrome [RCV005024557]uncertain significance3189886387189886387Human1alternate_id
597716335CV3717407single nucleotide variantNM_003722.5(TP63):c.1362G>T (p.Gln454His)ADULT syndrome [RCV005035289]uncertain significance3189886406189886406Human1alternate_id
597637893CV3717408single nucleotide variantNM_003722.5(TP63):c.1525C>T (p.His509Tyr)ADULT syndrome [RCV005024558]uncertain significance3189889357189889357Human1alternate_id
597716360CV3717409single nucleotide variantNM_003722.5(TP63):c.1528A>G (p.Met510Val)ADULT syndrome [RCV005035291]uncertain significance3189889360189889360Human1alternate_id
597637899CV3717410single nucleotide variantNM_003722.5(TP63):c.1534A>G (p.Met512Val)ADULT syndrome [RCV005024559]uncertain significance3189889366189889366Human1alternate_id
597716369CV3717411single nucleotide variantNM_003722.5(TP63):c.1565C>T (p.Thr522Ile)ADULT syndrome [RCV005035292]uncertain significance3189889397189889397Human1alternate_id
597637910CV3717412single nucleotide variantNM_003722.5(TP63):c.1615C>T (p.Pro539Ser)ADULT syndrome [RCV005024561]uncertain significance3189889447189889447Human1alternate_id
597716381CV3717413single nucleotide variantNM_003722.5(TP63):c.1797G>A (p.Lys599=)ADULT syndrome [RCV005035293]uncertain significance3189894256189894256Human1alternate_id
597637916CV3717414single nucleotide variantNM_003722.5(TP63):c.1835C>A (p.Ser612Tyr)ADULT syndrome [RCV005024562]uncertain significance3189894294189894294Human1alternate_id
597637922CV3717415single nucleotide variantNM_003722.5(TP63):c.1847T>G (p.Leu616Arg)ADULT syndrome [RCV005024563]uncertain significance3189894306189894306Human1alternate_id
597637928CV3717416single nucleotide variantNM_003722.5(TP63):c.2009A>G (p.Asn670Ser)ADULT syndrome [RCV005024564]uncertain significance3189894468189894468Human1alternate_id
597637933CV3717417single nucleotide variantNM_003722.5(TP63):c.2036G>A (p.Gly679Glu)ADULT syndrome [RCV005024565]uncertain significance3189894495189894495Human1alternate_id
598188445CV4008583microsatelliteNM_001329964.2(TP63):c.22_23del (p.Asp8fs)ADULT syndrome [RCV005396082]uncertain significance3189597199189597200Humanalternate_id
13836449CV587723single nucleotide variantNM_003722.5(TP63):c.290G>A (p.Arg97His)ADULT syndrome [RCV005004394]|TP63-Related Spectrum Disorders [RCV001855687]|TP63-related disorder [RCV004745572]|not provided [RCV000732570]uncertain significance3189738740189738740Human10alternate_id
15139714CV691358single nucleotide variantNM_003722.5(TP63):c.402T>C (p.Tyr134=)ADULT syndrome [RCV002478994]|TP63-Related Spectrum Disorders [RCV002064880]likely benign3189808349189808349Human9alternate_id
15139742CV691359single nucleotide variantNM_003722.5(TP63):c.714G>A (p.Thr238=)ADULT syndrome [RCV002507540]|TP63-Related Spectrum Disorders [RCV005056655]likely benign3189864366189864366Human9alternate_id
15142189CV691360single nucleotide variantNM_003722.5(TP63):c.1788G>A (p.Ala596=)ADULT syndrome [RCV002495327]|TP63-Related Spectrum Disorders [RCV002064892]|TP63-related disorder [RCV003967945]benign|likely benign3189894247189894247Human9alternate_id
15153493CV697987single nucleotide variantNM_003722.5(TP63):c.1599C>T (p.Ser533=)ADULT syndrome [RCV002505406]|TP63-Related Spectrum Disorders [RCV001479077]|TP63-related disorder [RCV003925862]|not provided [RCV000946092]likely benign3189889431189889431Human9alternate_id
15109403CV708731single nucleotide variantNM_003722.5(TP63):c.366G>A (p.Gln122=)ADULT syndrome [RCV002505442]|TP63-Related Spectrum Disorders [RCV002066373]|not provided [RCV000960693]benign|likely benign3189808313189808313Human9alternate_id
15145057CV733957single nucleotide variantNM_003722.5(TP63):c.84T>G (p.His28Gln)ADULT syndrome [RCV005029527]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV001144653]|Orofacial cleft 8 [RCV001144652]|TP63-Related Spectrum Disorders [RCV001144654]benign|likely benign|uncertain significance3189737761189737761Human10alternate_id
15113394CV787261single nucleotide variantNM_003722.5(TP63):c.992+8G>AADULT syndrome [RCV002505488]|TP63-Related Spectrum Disorders [RCV002066467]likely benign3189867950189867950Human9alternate_id
21071281CV790373single nucleotide variantNM_003722.5(TP63):c.1528A>T (p.Met510Leu)ADULT syndrome [RCV005029546]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV000987374]|TP63-Related Spectrum Disorders [RCV001858664]uncertain significance3189889360189889360Human10alternate_id
8625584CV80708single nucleotide variantNM_003722.5(TP63):c.1825G>A (p.Glu609Lys)ADULT syndrome [RCV002504980]|Split hand-foot malformation 4 [RCV001270760]uncertain significance|not provided3189894284189894284Human2alternate_id
28904884CV888501single nucleotide variantNM_003722.5(TP63):c.210G>C (p.Gln70His)ADULT syndrome [RCV005029719]|Ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3 [RCV001144655]|Orofacial cleft 8 [RCV001144656]|TP63-Related Spectrum Disorders [RCV001144657]benign|likely benign|uncertain significance3189738660189738660Human10alternate_id